About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Visit our Heart Failure Management Hub to discover a range of educational content to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for HF.

Articles

Cardiac Iodine-123 Metaiodobenzylguanidine Imaging for Risk Stratification in Heart Failure Patients

Citation:

European Cardiology 2008;4(2):42–5

Abortion of Acute Myocardial Infarction - The Best Possible Achievement of Reperfusion Therapy

Citation:

European Cardiology 2008;4(2):52–4

Dual-source Computed Tomography in Paediatric Congenital Heart Disease Patients - Combination of Low-kilovoltage Protocols and Ultravist Injection

Citation:

European Cardiology 2008;4(1):41–4

B-type Natriuretic Peptides in the Management of Acute Heart Failure and Acute Coronary Syndromes

Citation:

European Cardiovascular Disease 2007;3(2):22–3